Laura Girardi: Medical Inpatients’ Thromboprophylaxis – Was It All Already Said?
Laura Girardi, Clinical and Research Thrombosis Fellow at The Ottawa Hospital, reposted from JAMA Network Open on LinkedIn:
”Medical inpatients’ thromboprophylaxis: was it all already said?
Probably not!
If interested in the topic, you can have a look at the latest SRNMA just published on JAMA Network Open.
Truly honored to have been part of this incredible team led by colleagues Marti C and Blondon Marc (with Marc Righini, Grégoire Le Gal, Helia Robert-Ebadi, Combescure C, Jean-Luc Reny).
Thank you all!”
Quoting JAMA Network Open‘s post:
”Patients hospitalized for acute medical illness who received low-molecular-weight heparin had lower risk of clinically relevant VTE and major bleeding compared with direct oral anticoagulants or unfractionated heparin.”
Title: Pharmacologic Thromboprophylaxis in Medical Inpatients. A Systematic Review and Network Meta-Analysis
Authors: Christophe Marti, Marc Righini, Grégoire Le Gal, Laura Girardi, Helia Robert-Ebadi, Christophe Combescure, Jean-Luc Reny, Marc Blondon
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation
-
Jul 9, 2026, 19:00Wolfgang Miesbach: ISTH 2026 Showcases the Future of Gene Therapy
-
Jul 9, 2026, 18:21Martin Vanden Eede: Can We Safely Reduce Anticoagulation During ECMO?
-
Jul 9, 2026, 18:00Dorothée Faille: Discovering Versailles During ISTH 2026
-
Jul 9, 2026, 16:45Rutbaa Ayaz Shaikh: One Step Further in Medical Research
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock